Strategies for Reducing the Risk of Diabetes and Cancer
摘要
The increased global burden of diabetes mellitus and cancer has necessitated a paradigm shift toward preventive, integrative, and evidence-driven strategies targeting their shared etiological determinants. This chapter presents an in-depth analysis of scientifically validated interventions aimed at mitigating the dual risk of these chronic diseases through lifestyle modification, metabolic regulation, and behavioral restructuring. The chapter also emphasizes the mechanistic role of dietary composition, energy balance, and adiposity control in interrupting the mechanisms linking metabolic dysfunction with carcinogenesis. The chapter elucidates how diets enriched with whole grains, fruits, vegetables, polyphenols, omega-3 fatty acids, and antioxidants counteract hyperinsulinemia, oxidative stress, and chronic inflammation, which are the key molecular drivers of both diabetes and tumor development. In contrast, excess consumption of saturated fats, processed foods, and alcohol, alongside physical inactivity, contributes to insulin resistance, adipose tissue dysfunction, and systemic inflammatory signaling that fosters a pro-tumorigenic environment. Furthermore, the chapter examines the impact of obesity as a metabolic and hormonal disruptor that alters cytokine profiles, induces DNA damage through reactive oxygen species, and modulates growth factor pathways that are implicated in oncogenesis. The chapter also focuses on the beneficial role of Mediterranean diet and aerobic and resistance-based physical activity as an important strategy for disease prevention. The integration of these interventions into personalized healthcare models, public health policies, and clinical practice is an important factor for curbing the interlinked epidemics of diabetes and cancer. Toward the end, the chapter presents a translational perspective that unites molecular understanding with public health implementation, advancing a healthcare model that prioritizes prevention over treatment in managing intertwined metabolic and neoplastic disorders.